| Hepatitis B virus (HBV) infection is a serious healthy problem. Approximately400million people worldwide are hepatitis B virus carriers, of which10%â€20%will develop into cirrhosis and1%to5%into liver failure. China is hepatitis B virus highly infectionâ€prone area with about93million hepatitis B virus carriers, and nearly90%of them get infected during the infant or childhood. Once infected with HBV, the virus will begin to interact with the immune system of human body. A large quantity of literatures suggest that immune response is essential for viral clearance, but the HBV nonspecific immune factors will cause damage to liver.CD4+T cells may provide cofactors and induce a cytotoxic T cell generation, thus play an important role in the pathogenesis of hepatitis B. In recent years, a group of new CD4+T cells were suggested to be unlike traditional Th1, Th2cells and can secrete large amounts of ILâ€17as proâ€inflammatory cells. ILâ€17has played an important role in autoimmune diseases, allergic diseases and infectious diseases. Studies have shown that highconcentration of ILâ€17was foundinthe livers ofpatients with chronic hepatitis B,which wasassociated with liver damage. In addition, ILâ€17facilitates liver inflammationbymodulating the generation ofgranulocyte,inducing cells to relaseproinflammatoryfactors, and initiating the mobilization of neutrophils. However, the pathologicaleffectof ILâ€17uponchronic hepatitis B in adolescentsis less fullyinvestigated.Objective: Toanalyze the relevance betweenclinical indicatorsand the frequency of Th17cells detectedin the peripheral blood of children with CHB, thus toexplorethe antiâ€infectioussignificance ofTh17cells in the body’s immunityof adolecences. |